Dottikon ES Holding AG (SWX:DESN)

Market Cap	5.39B +99.2%
Revenue (ttm)	432.92M +28.3%
Net Income	120.97M +60.2%
EPS	8.75 +60.2%
Shares Out	13.82M
PE Ratio	44.56
Forward PE	38.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,210
Open	386.50
Previous Close	390.00
Day's Range	376.50 - 395.50
52-Week Range	245.00 - 396.00
Beta	0.97
Analysts	Hold
Price Target	412.50 (+5.23%)
Earnings Date	May 29, 2026

About Dottikon ES Holding AG

Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries in Europe, Switzerland, the United States, and Asia. The company’s chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compound...

• Industry: Chemicals
• Sector: Materials
• Founded: 1913
• Employees: 875
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: DESN

Financial Performance

In fiscal year 2025, Dottikon ES Holding AG's revenue was 392.68 million, an increase of 17.93% compared to the previous year's 332.98 million. Earnings were 105.58 million, an increase of 30.95%.